Alopecia Clinical Trials 2023

What are the top hospitals conducting alopecia research?

When it comes to advancing research and treatment options for alopecia, several top hospitals are making remarkable contributions. In the vibrant city of New York, the Icahn School of Medicine at Mount Sinai leads the charge with six active trials focused on alopecia, building upon their history of 15 previous studies in this field since their first recorded trial in 2015. Meanwhile, ForCare Clinical Research in Tampa, Florida is also playing a significant role by currently conducting five alopecia trials. Since initiating their inaugural trial in 2018, they have already completed eight studies dedicated to understanding and treating this condition.

In Indianapolis, the Dawes Fretzin Clinical Research Group has been actively involved in furthering our knowledge about alopecia through four current clinical trials. With a total of ten completed studies under their belt since starting their first trial in 2016, this institution continues to contribute valuable insights into potential therapies for those affected by alopecia.

Moving further west towards Portland, NW Dermatology & Research Center LLC is focusing its efforts on four ongoing clinical trials for alopecia. Despite having a more recent start with their initial recorded trial taking place in 2015; they're steadily expanding our understanding and exploring various treatment possibilities for individuals living with this condition.

Lastly but certainly not least important is Dermatology Specialists of Charlotte situated within North Carolinar alopecia, several top hospitals are making remarkable contributions. In the vibrant city of New York, the Icahn School of Medicine at Mount Sinai leads the charge with six active trials focused on alopecia, building upon their history of 15 previous studies in this field since their first recorded trial in 2015. Meanwhile, ForCare Clinical Research in Tampa, Florida is also playing a significant role by currently conducting five alopecia trials. Since initiating their inaugural trial in 2018, they have already completed eight studies dedicated to understanding and treating this condition.

In Indianapolis, the Dawes Fretzin Clinical Research Group has been actively involved in furthering our knowledge about alopecia through four current clinical trials. With a total of ten completed studies under their belt since starting their first trial in 2016, this institution continues to contribute valuable insights into potential therapies for those affected by alopecia.

Moving further west towards Portland, NW Dermatology & Research Center LLC is focusing its efforts on four ongoing clinical trials for alopecia. Despite having a more recent start with their initial recorded trial taking place in 2015; they're steadily expanding our understanding and exploring various treatment possibilities for individuals living with this condition.

Lastly but certainly not least important is Dermatology Specialists of Charlotte situated within North Carolina's charismatic city - Charlotte - where three active clinical trials are aimed at addressing the challenges faced by individuals with alopecia. While theirs can be seen as relatively recent endeavors marked only from commencement during year two thousand nineteen- that timeframe still accounts witnessing great strides made towards finding novel solutions promoting healthy hair growth proudly placing them amongst pioneers endeavoring better lives despite loss suffered due Alopecic conditions across regions nationwide

These specialized hospitals demonstrate unwavering commitment and dedication toward unraveling mysteries surrounding alopecia while striving tirelessly to find effective treatments and improve quality of life for those affected by this condition worldwide

Which are the best cities for alopecia clinical trials?

When it comes to alopecia clinical trials, several cities stand out as prominent research hubs. New York, San Antonio, and Portland all have 13 active trials each, focusing on various treatments such as Dupilumab, CTP-543, Baricitinib, and more. Minneapolis follows closely behind with 12 ongoing studies involving PF-06651600 and other interventions. Lastly, New Haven offers 10 active trials investigating treatments like Baricitinib and PF-06651600. These cities provide individuals dealing with alopecia an opportunity to participate in cutting-edge clinical research that may lead to advancements in treatment options for this condition.

Which are the top treatments for alopecia being explored in clinical trials?

Exciting developments are underway in the field of alopecia research, with several cutting-edge treatments currently being explored in clinical trials. Leading the charge is PF-06651600, a promising drug that has caught the attention of researchers worldwide. With three active trials and four all-time alopecia trials since its introduction in 2016, it shows great potential for addressing this challenging condition. Additionally, baricitinib and dupilumab have also emerged as strong contenders, each with two active and three all-time alopecia trials to their names. These innovative treatments may hold the key to unlocking new possibilities for individuals affected by alopecia, offering hope where there was once only frustration.

What are the most recent clinical trials for alopecia?

Exciting advancements are being made in the field of alopecia, with recent clinical trials offering promising possibilities for treatment. Among these trials is ADX-914, an experimentalf alopecia, with recent clinical trials offering promising possibilities for treatment. Among these trials is ADX-914, an experimental drug currently in Phase 2 testing, which could hold potential for individuals suffering from alopecia. Another trial that has shown promise is farudodstat, also in Phase 2, as well as dupilumab and oral minoxidil both at the same stage of development. Additionally, a topical solution called TDM-105795 is undergoing Phase 2 testing and may provide new options for those affected by alopecia. With these innovative studies underway, there is hope on the horizon for finding effective solutions to combat this condition.

What alopecia clinical trials were recently completed?

Recent clinical trials investigating potential treatments for alopecia have yielded promising results, offering hope to individuals affected by this condition. In April 2022, LEO Pharma completed a trial evaluating the efficacy of Delgocitinib cream. Similarly, in February 2022, Suzhou Kintor Pharmaceutical Inc. wrapped up a trial testing the GT20029 Gel treatment. Additionally, Technoderma Medicines Inc.'s TDM-105795 therapy underwent two separate trials that were completed in February 2022 and April 2021 respectively. Concert Pharmaceuticals' CTP-543 also demonstrated progress through its completion of a trial in February 2021. Although slightly further back on the timeline, Pfizer concluded their Etrasimod trial in July 2020 and the University of Arizona wrapped up their Keratinocyte growth factor study in April of that same year — both representing noteworthy contributions to alopecia research endeavors.